178 related articles for article (PubMed ID: 11690617)
1. Improving axonal growth and functional recovery after experimental spinal cord injury by neutralizing myelin associated inhibitors.
Fouad K; Dietz V; Schwab ME
Brain Res Brain Res Rev; 2001 Oct; 36(2-3):204-12. PubMed ID: 11690617
[TBL] [Abstract][Full Text] [Related]
2. Anti-Nogo-A antibody treatment enhances sprouting of corticospinal axons rostral to a unilateral cervical spinal cord lesion in adult macaque monkey.
Freund P; Wannier T; Schmidlin E; Bloch J; Mir A; Schwab ME; Rouiller EM
J Comp Neurol; 2007 Jun; 502(4):644-59. PubMed ID: 17394135
[TBL] [Abstract][Full Text] [Related]
3. Regenerating corticospinal fibers in the Marmoset (Callitrix jacchus) after spinal cord lesion and treatment with the anti-Nogo-A antibody IN-1.
Fouad K; Klusman I; Schwab ME
Eur J Neurosci; 2004 Nov; 20(9):2479-82. PubMed ID: 15525289
[TBL] [Abstract][Full Text] [Related]
4. Regeneration of lesioned corticospinal tract fibers in the adult rat induced by a recombinant, humanized IN-1 antibody fragment.
Brösamle C; Huber AB; Fiedler M; Skerra A; Schwab ME
J Neurosci; 2000 Nov; 20(21):8061-8. PubMed ID: 11050127
[TBL] [Abstract][Full Text] [Related]
5. Nogo-66 receptor antagonist peptide (NEP1-40) administration promotes functional recovery and axonal growth after lateral funiculus injury in the adult rat.
Cao Y; Shumsky JS; Sabol MA; Kushner RA; Strittmatter S; Hamers FP; Lee DH; Rabacchi SA; Murray M
Neurorehabil Neural Repair; 2008; 22(3):262-78. PubMed ID: 18056009
[TBL] [Abstract][Full Text] [Related]
6. Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor Nogo-A.
Merkler D; Metz GA; Raineteau O; Dietz V; Schwab ME; Fouad K
J Neurosci; 2001 May; 21(10):3665-73. PubMed ID: 11331396
[TBL] [Abstract][Full Text] [Related]
7. Nogo-A antibody improves regeneration and locomotion of spinal cord-injured rats.
Liebscher T; Schnell L; Schnell D; Scholl J; Schneider R; Gullo M; Fouad K; Mir A; Rausch M; Kindler D; Hamers FP; Schwab ME
Ann Neurol; 2005 Nov; 58(5):706-19. PubMed ID: 16173073
[TBL] [Abstract][Full Text] [Related]
8. Delayed anti-nogo-a antibody application after spinal cord injury shows progressive loss of responsiveness.
Gonzenbach RR; Zoerner B; Schnell L; Weinmann O; Mir AK; Schwab ME
J Neurotrauma; 2012 Feb; 29(3):567-78. PubMed ID: 21815784
[TBL] [Abstract][Full Text] [Related]
9. Intrathecally infused antibodies against Nogo-A penetrate the CNS and downregulate the endogenous neurite growth inhibitor Nogo-A.
Weinmann O; Schnell L; Ghosh A; Montani L; Wiessner C; Wannier T; Rouiller E; Mir A; Schwab ME
Mol Cell Neurosci; 2006; 32(1-2):161-73. PubMed ID: 16697217
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Nogo: a key strategy to increase regeneration, plasticity and functional recovery of the lesioned central nervous system.
Buchli AD; Schwab ME
Ann Med; 2005; 37(8):556-67. PubMed ID: 16338758
[TBL] [Abstract][Full Text] [Related]
11. Resistance of interleukin-6 to the extracellular inhibitory environment promotes axonal regeneration and functional recovery following spinal cord injury.
Yang G; Tang WY
Int J Mol Med; 2017 Feb; 39(2):437-445. PubMed ID: 28075461
[TBL] [Abstract][Full Text] [Related]
12. Anti-Nogo on the go: from animal models to a clinical trial.
Zörner B; Schwab ME
Ann N Y Acad Sci; 2010 Jun; 1198 Suppl 1():E22-34. PubMed ID: 20590535
[TBL] [Abstract][Full Text] [Related]
13. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
Kim JE; Liu BP; Park JH; Strittmatter SM
Neuron; 2004 Oct; 44(3):439-51. PubMed ID: 15504325
[TBL] [Abstract][Full Text] [Related]
14. Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury.
Li S; Strittmatter SM
J Neurosci; 2003 May; 23(10):4219-27. PubMed ID: 12764110
[TBL] [Abstract][Full Text] [Related]
15. Invasion of lesion territory by regenerating fibers after spinal cord injury in adult macaque monkeys.
Beaud ML; Rouiller EM; Bloch J; Mir A; Schwab ME; Wannier T; Schmidlin E
Neuroscience; 2012 Dec; 227():271-82. PubMed ID: 23036616
[TBL] [Abstract][Full Text] [Related]
16. Sequential therapy of anti-Nogo-A antibody treatment and treadmill training leads to cumulative improvements after spinal cord injury in rats.
Chen K; Marsh BC; Cowan M; Al'Joboori YD; Gigout S; Smith CC; Messenger N; Gamper N; Schwab ME; Ichiyama RM
Exp Neurol; 2017 Jun; 292():135-144. PubMed ID: 28341461
[TBL] [Abstract][Full Text] [Related]
17. PKC mediates inhibitory effects of myelin and chondroitin sulfate proteoglycans on axonal regeneration.
Sivasankaran R; Pei J; Wang KC; Zhang YP; Shields CB; Xu XM; He Z
Nat Neurosci; 2004 Mar; 7(3):261-8. PubMed ID: 14770187
[TBL] [Abstract][Full Text] [Related]
18. Ameliorative Effects of p75NTR-ED-Fc on Axonal Regeneration and Functional Recovery in Spinal Cord-Injured Rats.
Wang YT; Lu XM; Zhu F; Huang P; Yu Y; Long ZY; Wu YM
Mol Neurobiol; 2015 Dec; 52(3):1821-1834. PubMed ID: 25394381
[TBL] [Abstract][Full Text] [Related]
19. Ibuprofen enhances recovery from spinal cord injury by limiting tissue loss and stimulating axonal growth.
Wang X; Budel S; Baughman K; Gould G; Song KH; Strittmatter SM
J Neurotrauma; 2009 Jan; 26(1):81-95. PubMed ID: 19125588
[TBL] [Abstract][Full Text] [Related]
20. Immunization with myelin or recombinant Nogo-66/MAG in alum promotes axon regeneration and sprouting after corticospinal tract lesions in the spinal cord.
Sicotte M; Tsatas O; Jeong SY; Cai CQ; He Z; David S
Mol Cell Neurosci; 2003 Jun; 23(2):251-63. PubMed ID: 12812757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
